Trump Administration Picks Five Companies in Operation Warp Speed

June 7, 2020

The Trump administration has selected five drugmakers as being most likely to develop a coronavirus vaccine, The New York Times reports.

According to the report, the five companies are Moderna, a partnership between Oxford University and AstraZeneca, Johnson & Johnson, Merck and Pfizer.

National Institute of Allergy and Infectious Diseases Director Anthony Fauci recently told a medical seminar “by the beginning of 2021 we hope to have a couple of hundred million doses.”

To read the full report on The New York Times, click here.

Click here to read Fierce Pharma’s coverage of the announcement.

Share This Story!